Rituximab in Metastatic Melanoma
Clinical trial NCT01032122 · TERMINATED
Trial details
- NCT number
- NCT01032122
- Sponsor
- Medical University of Vienna
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.